Hiroyuki Uchida, MD, PhD

Original Research

Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study

July 22, 2014

Original Research

Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data

May 15, 2014

Article

A Cross-Sectional Study of Plasma Risperidone Levels With Risperidone Long-Acting Injectable: Implications for Dopamine D2 Receptor Occupancy During Maintenance Treatment in Schizophrenia

August 15, 2012

Article

How Successful Are Physicians in Eliciting the Truth From Their Patients? A Large-Scale Internet Survey From Patients' Perspectives

March 15, 2012

Original Research

Increased Antipsychotic Sensitivity in Elderly Patients: Evidence and Mechanisms

December 16, 2009

Letter to the Editor

Selective Serotonin Reuptake Inhibitor-Induced Spermatorrhea in 2 Patients

August 15, 2009

Original Research

Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia

August 31, 2008

Original Research

Quetiapine Extended-Release Versus Immediate-Release Formulation: A Positron Emission Tomography Study

January 15, 2008